These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29605422)

  • 1. Leukocytoclastic Vasculitis and Desensitization to High-dose Methotrexate in Primary Central Nervous System Lymphoma.
    Hanna C; Villa D; Irani C; Ghosn M; El Rassy E
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):e197-e200. PubMed ID: 29605422
    [No Abstract]   [Full Text] [Related]  

  • 2. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
    Khan RB; Shi W; Thaler HT; DeAngelis LM; Abrey LE
    J Neurooncol; 2002 Jun; 58(2):175-8. PubMed ID: 12164690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?
    Dalia S; Price S; Forsyth P; Sokol L; Jaglal M
    Leuk Lymphoma; 2015 Feb; 56(2):500-2. PubMed ID: 24882264
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET; Altundag K; Aksoy S; Onal IK; Tekuzman G
    Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
    [No Abstract]   [Full Text] [Related]  

  • 5. Urine volume to hydration volume ratio is associated with pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma.
    Isono T; Hira D; Morikochi A; Fukami T; Ueshima S; Nozaki K; Terada T; Morita SY
    Pharmacol Res Perspect; 2021 Dec; 9(6):e00883. PubMed ID: 34664791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readministration of high-dose methotrexate in a patient with suspected immediate hypersensitivity and T-cell acute lymphoblastic lymphoma.
    Kohli A; Ferencz TM; Calderon JG
    Allergy Asthma Proc; 2004; 25(4):249-52. PubMed ID: 15510585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
    Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
    Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic high-dose intravenous methotrexate for central nervous system metastases.
    Lassman AB; Abrey LE; Shah GD; Panageas KS; Begemann M; Malkin MG; Raizer JJ
    J Neurooncol; 2006 Jul; 78(3):255-60. PubMed ID: 16344918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
    Xie H; Peereboom DM
    J Clin Oncol; 2012 Jul; 30(21):e192-4. PubMed ID: 22711852
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate-induced systemic vasculitis.
    Yoruk A; Cizmecioglu F; Yukselgungor H; Timur C; Baydilli H; Ozcay S
    Med Pediatr Oncol; 2002 Feb; 38(2):139-40. PubMed ID: 11813187
    [No Abstract]   [Full Text] [Related]  

  • 12. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T; Costa V; Silva I; Oliva T; Norton L
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytoclastic vasculitis associated with methotrexate therapy.
    Düzova A; Soysal A; Ozen S; Akyüz C; Gököz A; Yetgin S
    Turk J Pediatr; 2000; 42(3):267-8. PubMed ID: 11105634
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational administration schedule for high-dose methotrexate in patients with primary central nervous system lymphoma.
    Joerger M; Huitema AD; Illerhaus G; Ferreri AJ
    Leuk Lymphoma; 2012 Oct; 53(10):1867-75. PubMed ID: 22530664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
    Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
    Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S; Giryes H; Avinoach I; Livni E; Sukenik S
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):81-5. PubMed ID: 9552765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma.
    Jahnke K; Korfel A; Martus P; Weller M; Herrlinger U; Schmittel A; Fischer L; Thiel E;
    Ann Oncol; 2005 Mar; 16(3):445-9. PubMed ID: 15653703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of polyglutamylation in primary central nervous system lymphoma.
    Shinojima N; Fujimoto K; Makino K; Todaka K; Yamada K; Mikami Y; Oda K; Nakamura K; Jono H; Kuratsu JI; Nakamura H; Yano S; Mukasa A
    Acta Neuropathol Commun; 2018 Feb; 6(1):15. PubMed ID: 29475458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.